UNIVERSAL TECHNICAL INSTITUT (UTI) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:UTI - US9139151040 - Common Stock
22.66 USD
-0.8 (-3.41%)
22.9374 USD
+0.28 (+1.22%)
Taking everything into account, UTI scores 5 out of 10 in our fundamental rating. UTI was compared to 77 industry peers in the Diversified Consumer Services industry. While UTI has a great profitability rating, there are some minor concerns on its financial health. UTI is valued correctly, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year UTI was profitable.
UTI had a positive operating cash flow in the past year.
Of the past 5 years UTI 4 years were profitable.
UTI had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
UTI's Return On Assets of 8.52% is fine compared to the rest of the industry. UTI outperforms 75.95% of its industry peers.
UTI has a Return On Equity of 20.57%. This is amongst the best in the industry. UTI outperforms 86.08% of its industry peers.
With an excellent Return On Invested Capital value of 10.86%, UTI belongs to the best of the industry, outperforming 82.28% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for UTI is below the industry average of 9.57%.
The last Return On Invested Capital (10.86%) for UTI is above the 3 year average (5.11%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.52% | ||
| ROE | 20.57% | ||
| ROIC | 10.86% |
ROA(3y)2.68%
ROA(5y)2.09%
ROE(3y)7.52%
ROE(5y)5.81%
ROIC(3y)5.11%
ROIC(5y)N/A
1.3 Margins
Looking at the Profit Margin, with a value of 7.79%, UTI is in the better half of the industry, outperforming 67.09% of the companies in the same industry.
In the last couple of years the Profit Margin of UTI has grown nicely.
With a decent Operating Margin value of 10.44%, UTI is doing good in the industry, outperforming 67.09% of the companies in the same industry.
In the last couple of years the Operating Margin of UTI has grown nicely.
UTI has a Gross Margin of 49.65%. This is comparable to the rest of the industry: UTI outperforms 53.16% of its industry peers.
In the last couple of years the Gross Margin of UTI has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 10.44% | ||
| PM (TTM) | 7.79% | ||
| GM | 49.65% |
OM growth 3Y21.82%
OM growth 5YN/A
PM growth 3Y23.23%
PM growth 5YN/A
GM growth 3Y-14.8%
GM growth 5Y-8.67%
2. Health
2.1 Basic Checks
UTI has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
There is no outstanding debt for UTI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
UTI has an Altman-Z score of 3.33. This indicates that UTI is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of UTI (3.33) is better than 78.48% of its industry peers.
The Debt to FCF ratio of UTI is 0.99, which is an excellent value as it means it would take UTI, only 0.99 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 0.99, UTI belongs to the best of the industry, outperforming 83.54% of the companies in the same industry.
UTI has a Debt/Equity ratio of 0.23. This is a healthy value indicating a solid balance between debt and equity.
UTI has a Debt to Equity ratio of 0.23. This is comparable to the rest of the industry: UTI outperforms 54.43% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.23 | ||
| Debt/FCF | 0.99 | ||
| Altman-Z | 3.33 |
ROIC/WACC1.28
WACC8.48%
2.3 Liquidity
UTI has a Current Ratio of 1.00. This is a normal value and indicates that UTI is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.00, UTI is in line with its industry, outperforming 41.77% of the companies in the same industry.
A Quick Ratio of 1.00 indicates that UTI should not have too much problems paying its short term obligations.
The Quick ratio of UTI (1.00) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1 | ||
| Quick Ratio | 1 |
3. Growth
3.1 Past
UTI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 54.05%, which is quite impressive.
Measured over the past 5 years, UTI shows a small growth in Earnings Per Share. The EPS has been growing by 3.11% on average per year.
EPS 1Y (TTM)54.05%
EPS 3Y3.11%
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%13.28%
3.2 Future
The Earnings Per Share is expected to decrease by -3.86% on average over the next years.
Based on estimates for the next years, UTI will show a quite strong growth in Revenue. The Revenue will grow by 8.52% on average per year.
EPS Next Y-18.25%
EPS Next 2Y-3.86%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year8.25%
Revenue Next 2Y8.52%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
UTI is valuated rather expensively with a Price/Earnings ratio of 19.88.
Based on the Price/Earnings ratio, UTI is valued a bit cheaper than the industry average as 62.03% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 25.47. UTI is valued slightly cheaper when compared to this.
Based on the Price/Forward Earnings ratio of 24.31, the valuation of UTI can be described as rather expensive.
UTI's Price/Forward Earnings is on the same level as the industry average.
UTI is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 34.42, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.88 | ||
| Fwd PE | 24.31 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, UTI is valued a bit cheaper than 67.09% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of UTI indicates a somewhat cheap valuation: UTI is cheaper than 70.89% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 16.5 | ||
| EV/EBITDA | 9.35 |
4.3 Compensation for Growth
The decent profitability rating of UTI may justify a higher PE ratio.
A cheap valuation may be justified as UTI's earnings are expected to decrease with -3.86% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-3.86%
EPS Next 3YN/A
5. Dividend
5.1 Amount
UTI does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
22.66
-0.8 (-3.41%)
Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)
Earnings (Next)
Inst Owners94.48%
Inst Owner Change-1.21%
Ins Owners2.24%
Ins Owner Change0.24%
Market Cap1.23B
Revenue(TTM)N/A
Net Income(TTM)63.10M
Analysts81.82
Price Target38.18 (68.49%)
Short Float %3.67%
Short Ratio2.95
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0.03
Dividend Growth(5Y)-34.43%
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)71.27%
Min EPS beat(2)69.26%
Max EPS beat(2)73.27%
EPS beat(4)4
Avg EPS beat(4)69.47%
Min EPS beat(4)12.21%
Max EPS beat(4)123.12%
EPS beat(8)7
Avg EPS beat(8)80.23%
EPS beat(12)10
Avg EPS beat(12)129.78%
EPS beat(16)14
Avg EPS beat(16)215.22%
Revenue beat(2)2
Avg Revenue beat(2)2.83%
Min Revenue beat(2)1.15%
Max Revenue beat(2)4.51%
Revenue beat(4)4
Avg Revenue beat(4)2.54%
Min Revenue beat(4)1.15%
Max Revenue beat(4)4.51%
Revenue beat(8)8
Avg Revenue beat(8)2.39%
Revenue beat(12)11
Avg Revenue beat(12)2.98%
Revenue beat(16)15
Avg Revenue beat(16)3.43%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-6.02%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.58%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.11%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.04%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.88 | ||
| Fwd PE | 24.31 | ||
| P/S | 1.52 | ||
| P/FCF | 16.5 | ||
| P/OCF | 11.44 | ||
| P/B | 4.02 | ||
| P/tB | 4.73 | ||
| EV/EBITDA | 9.35 |
EPS(TTM)1.14
EY5.03%
EPS(NY)0.93
Fwd EY4.11%
FCF(TTM)1.37
FCFY6.06%
OCF(TTM)1.98
OCFY8.74%
SpS14.88
BVpS5.64
TBVpS4.79
PEG (NY)N/A
PEG (5Y)N/A
Graham Number12.02
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.52% | ||
| ROE | 20.57% | ||
| ROCE | 15.21% | ||
| ROIC | 10.86% | ||
| ROICexc | 13.78% | ||
| ROICexgc | 15.4% | ||
| OM | 10.44% | ||
| PM (TTM) | 7.79% | ||
| GM | 49.65% | ||
| FCFM | 9.23% |
ROA(3y)2.68%
ROA(5y)2.09%
ROE(3y)7.52%
ROE(5y)5.81%
ROIC(3y)5.11%
ROIC(5y)N/A
ROICexc(3y)7.05%
ROICexc(5y)N/A
ROICexgc(3y)7.97%
ROICexgc(5y)N/A
ROCE(3y)7.15%
ROCE(5y)N/A
ROICexgc growth 3Y41.64%
ROICexgc growth 5YN/A
ROICexc growth 3Y37.09%
ROICexc growth 5YN/A
OM growth 3Y21.82%
OM growth 5YN/A
PM growth 3Y23.23%
PM growth 5YN/A
GM growth 3Y-14.8%
GM growth 5Y-8.67%
F-Score6
Asset Turnover1.09
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.23 | ||
| Debt/FCF | 0.99 | ||
| Debt/EBITDA | 0.58 | ||
| Cap/Depr | 87.82% | ||
| Cap/Sales | 4.08% | ||
| Interest Coverage | 11.6 | ||
| Cash Conversion | 88.25% | ||
| Profit Quality | 118.43% | ||
| Current Ratio | 1 | ||
| Quick Ratio | 1 | ||
| Altman-Z | 3.33 |
F-Score6
WACC8.48%
ROIC/WACC1.28
Cap/Depr(3y)259.47%
Cap/Depr(5y)259.17%
Cap/Sales(3y)10.54%
Cap/Sales(5y)10.62%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)54.05%
EPS 3Y3.11%
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y-18.25%
EPS Next 2Y-3.86%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%13.28%
Revenue Next Year8.25%
Revenue Next 2Y8.52%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y85.69%
EBIT growth 3Y58.11%
EBIT growth 5YN/A
EBIT Next Year114.2%
EBIT Next 3Y30.39%
EBIT Next 5YN/A
FCF growth 1Y395.38%
FCF growth 3YN/A
FCF growth 5Y32.12%
OCF growth 1Y222.73%
OCF growth 3Y15.89%
OCF growth 5Y31.61%
UNIVERSAL TECHNICAL INSTITUT / UTI FAQ
What is the fundamental rating for UTI stock?
ChartMill assigns a fundamental rating of 5 / 10 to UTI.
Can you provide the valuation status for UNIVERSAL TECHNICAL INSTITUT?
ChartMill assigns a valuation rating of 4 / 10 to UNIVERSAL TECHNICAL INSTITUT (UTI). This can be considered as Fairly Valued.
Can you provide the profitability details for UNIVERSAL TECHNICAL INSTITUT?
UNIVERSAL TECHNICAL INSTITUT (UTI) has a profitability rating of 7 / 10.
What are the PE and PB ratios of UNIVERSAL TECHNICAL INSTITUT (UTI) stock?
The Price/Earnings (PE) ratio for UNIVERSAL TECHNICAL INSTITUT (UTI) is 19.88 and the Price/Book (PB) ratio is 4.02.
Can you provide the expected EPS growth for UTI stock?
The Earnings per Share (EPS) of UNIVERSAL TECHNICAL INSTITUT (UTI) is expected to decline by -18.25% in the next year.